Q+A: The GLP-1 drugs changing health and markets
Published January 29, 2026
Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.
Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.